US EditionUNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer - UNC Lineberger
Summary by unclineberger.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer - UNC Lineberger
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy. The post UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer appeared first on UNC Lineberger.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
